- NEWS AND VIEWS
A persistent look at how tumours evade therapy
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 596, 491-493 (2021)
doi: https://doi.org/10.1038/d41586-021-02117-1
References
Oren, Y. et al. Nature 596, 576–582 (2021).
Salgia, R. & Kulkarni, P. Trends Cancer 4, 110–118 (2018).
Sharma, S. V. et al. Cell 141, 69–80 (2010).
Hata, A. N. et al. Nature Med. 22, 262–269 (2016).
Chen, P.-Y. et al. Cancer Res. 78, 985–1002 (2018).
Jolly, M. K., Kulkarni, P., Weninger, K., Orban, J. & Levine, H. Front. Oncol. 8, 50 (2018).
Garon, E. B. et al. J. Thorac. Oncol. 8, 270–278 (2013).
Angeli, J. P. F., Shah, R., Pratt, D. A. & Conrad, M. Trends Pharmacol. Sci. 38, 489–498 (2017).
Hangauer, M. J. et al. Nature 551, 247–250 (2017).
Competing Interests
The authors declare no competing interests.